Sign In
Buy EW
$86.00
-1.66 (-1.89%)
At Close: Jun 03, 2026
Edwards Lifesciences (EW) Earnings Expected to Grow: Should You Buy?
04:33pm, Tuesday, 19'th Apr 2022
Edwards Lifesciences (EW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON APRIL 26, 2022
07:05am, Tuesday, 19'th Apr 2022
IRVINE, Calif. , April 19, 2022 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2022 after the market closes on Tuesday, April
Edwards Lifesciences (EW) Gains But Lags Market: What You Should Know
10:15pm, Wednesday, 13'th Apr 2022 Zacks Investment Research
Edwards Lifesciences (EW) closed at $121.91 in the latest trading session, marking a +0.89% move from the prior day.
Expert Ratings for Edwards Lifesciences
05:02pm, Wednesday, 13'th Apr 2022 Benzinga
Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
2
5
0
0
0
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2022
02:01pm, Wednesday, 13'th Apr 2022 Benzinga
Upgrades
According to Oppenheimer, the prior rating for Apollo Global Management Inc (NYSE:APO) was changed from Perform to Outperform. In the fourth quarter, Apollo Global Management showed an EPS of
Abiomed (ABMD) Announces Successful Usage of Impella in Japan
05:14pm, Monday, 11'th Apr 2022 Zacks Investment Research
Continued adoption of Abiomed's (ABMD) Impella 5.5 with SmartAssist is likely to provide a minimally invasive surgical option for acute heart failure patients.
Cardinal Health (CAH) Hits 52-Week High: What's Aiding It?
04:28pm, Monday, 11'th Apr 2022 Zacks Investment Research
Investors are optimistic about Cardinal Health's (CAH) diversified product portfolio.
AmerisourceBergen's (ABC) Venture Capital Fund to Aid Healthcare
03:55pm, Monday, 11'th Apr 2022 Zacks Investment Research
AmerisourceBergen's (ABC) new corporate venture capital fund to help emerging healthcare startup companies change healthcare for people and animals globally.
Here's Why You Should Retain West Pharmaceutical (WST) Now
03:33pm, Monday, 11'th Apr 2022 Zacks Investment Research
West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex woes persist.
This is what you should do in the stock market now, according to three 2022 fund-award winners
01:18pm, Saturday, 09'th Apr 2022 MarketWatch
Don't get out of equities and start to favor growth strategies.
PerkinElmer (PKI) Boosts In Vivo Imaging Profile With New System
01:16pm, Friday, 08'th Apr 2022 Zacks Investment Research
PerkinElmer's (PKI) launch of the Vega imaging system is likely to help the company expand its in vivo imaging portfolio.
Edwards Lifesciences' (EW) Global Sales Robust Amid Cost Woes
11:17am, Friday, 08'th Apr 2022
Edwards Lifesciences (EW) is registering robust HemoSphere sales in the United States.
PerkinElmer's (PKI) New Assay Kits to Detect CHO HCP Impurities
03:12pm, Thursday, 07'th Apr 2022 Zacks Investment Research
PerkinElmer (PKI) launches ready-to-use HTRF and AlphaLISA no-wash assay kits to quickly identify and quantify CHO HCP impurities.
HOLX vs. EW: Which Stock Is the Better Value Option?
12:48pm, Tuesday, 05'th Apr 2022
HOLX vs. EW: Which Stock Is the Better Value Option?
7 Medical Device Stocks to Buy as Covid-19 Fears Fade
07:46am, Tuesday, 05'th Apr 2022
With concerns about Covid-19 fading into the rearview mirror, the normalization of healthcare could benefit these medical device stocks. The post 7 Medical Device Stocks to Buy as Covid-19 Fears Fade
